Key Insights

Highlights

Treatment Research

16 treatments under study, led by Thiotepa

Related Conditions

Often studied with 13 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Early Phase 1 (1)

Trial Status

Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT06942039Early Phase 1RecruitingPrimary

Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation

Showing all 1 trials

Research Network

Common Treatments

  • Thiotepa1
  • Cyclophosphamide1
  • Tamoxifen1
  • Carboplatin1
  • Etoposide Phosphate1

Active Sponsors

  • C17 Council1

Top Investigators

Related Conditions

  • Atypical Teratoid Rhabdoid Tumor1
  • Medulloblastoma Group 41
  • Embryonal Tumor With Abundant Neuropil And True Rosettes1
  • Cns Embryonal Tumor Nos1
  • Embryonal Tumor With Multilayered Rosettes1

Activity Timeline